Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristyn Galbraith

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuropathology and Experimental Neurology|July 11, 2020
Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma CohortsKristyn Galbraith, Ashwani Kumar, Kalil G Abdullah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Cell Genomics|February 21, 2026
Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsiesJamin Wu, Shih-Chun A Chu, Jang Cho, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuropathology and Experimental Neurology|July 11, 2020
Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma CohortsKristyn Galbraith, Ashwani Kumar, Kalil G Abdullah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Cell Genomics|February 21, 2026
Hi-C for genome-wide detection of enhancer-hijacking rearrangements in routine lymphoid cancer biopsiesJamin Wu, Shih-Chun A Chu, Jang Cho, et al.
Neuro-Oncology Advances|July 30, 2025
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumorsChristopher H Dampier, Niharika Shah, Kristyn Galbraith, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Neuro-Oncology|June 28, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndromeAnna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, et al.
Pageof 3